END-OF-TREATMENT QUANTITATIVE HBsAg < 500 IU/ML CAN PREDICT SUSTAINED REMISSION AND HBsAg LOSS AFTER DISCONTINUATION OF NUCLEOS(T)IDE ANALOGUES IN CHRONIC HEPATITIS B

Authors
Abdurakhmanov D.1 , Panevkina S.2 , Ibragimov E.1 , Rozina T.1, 2 , Nikulkina E.1 , Mazurchik N. 3
Conference proceedings
HEPATOLOGY
Publisher
WILEY-BLACKWELL
Language
English
Status
Published
Volume
72
Year
2020
Organizations
  • 1 Sechenov First Moscow State Med Univ, Moscow, Russia
  • 2 Lomonosov Moscow State Univ, Moscow, Russia
  • 3 Rudn Univ, Fac Med, Moscow, Russia
Date of creation
20.04.2021
Date of change
20.04.2021
Short link
https://repository.rudn.ru/en/records/article/record/73367/
Share

Other records